CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
出版年份 2020 全文链接
标题
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
作者
关键词
-
出版物
Cancers
Volume 12, Issue 5, Pages 1253
出版商
MDPI AG
发表日期
2020-05-18
DOI
10.3390/cancers12051253
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer
- (2020) Johanna Waidhauser et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Microenvironment, Metabolism, and Immunotherapy
- (2020) Ralph J. DeBerardinis NEW ENGLAND JOURNAL OF MEDICINE
- Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
- (2020) Ha Thi Thu Do et al. Cancers
- Molecular Profiling In Muscle Invasive Bladder Cancer: More Than The Sum Of Its Parts
- (2019) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
- (2019) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- The Tumor Immune Microenvironment Drives a Prognostic Relevance that Correlates with Bladder Cancer Subtypes
- (2019) Carolin Pfannstiel et al. Cancer Immunology Research
- The Natural History of Untreated Muscle Invasive Bladder Cancer
- (2019) Alberto Martini et al. BJU INTERNATIONAL
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy
- (2019) Wentao Zhang et al. Annals of Translational Medicine
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma
- (2019) Ruyi Xu et al. Cell Death & Disease
- Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
- (2019) Magdalene Joseph et al. Frontiers in Oncology
- The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
- (2018) Teizo Yoshimura Cellular & Molecular Immunology
- A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
- (2018) Markus Eckstein et al. Oncotarget
- Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors
- (2018) Tuan Zea Tan et al. EUROPEAN UROLOGY
- CC Chemokine Ligand 18 Promotes Cell Proliferation and Metastasis of Urothelial Carcinoma via Activating PI3K/mTOR Signaling in Patient with Renal Transplantation
- (2018) Song Bo et al. UROLOGIA INTERNATIONALIS
- LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
- (2018) Changhao Chen et al. Nature Communications
- Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma
- (2018) Yan-Li Li et al. ANNALS OF HEMATOLOGY
- Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study
- (2018) Yadong Guo et al. Cancer Management and Research
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
- (2017) Roland Seiler et al. EUROPEAN UROLOGY
- Notch Shapes the Innate Immunophenotype in Breast Cancer
- (2017) Qiang Shen et al. Cancer Discovery
- Non-muscle-invasive bladder cancer: a vision for the future
- (2017) Per-Uno Malmström et al. Scandinavian Journal of Urology
- Bladder cancer
- (2017) Oner Sanli et al. Nature Reviews Disease Primers
- The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review
- (2016) Michele Marchioni et al. Clinical Genitourinary Cancer
- CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
- (2016) Ryuichiro Arakaki et al. Cancer Medicine
- Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
- (2016) Vipulkumar Dadhania et al. EBioMedicine
- Unknown
- (2015) Helge Taubert et al. MOLECULAR MEDICINE
- Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals
- (2015) Qun Rao et al. Oncotarget
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Inflammatory Biomarkers and Bladder Cancer Prognosis: A Systematic Review
- (2014) Alexandra Masson-Lecomte et al. EUROPEAN UROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- High coexpression ofCCL2andCX3CL1is gender-specifically associated with good prognosis in soft tissue sarcoma patients
- (2014) Astrid Kehlen et al. INTERNATIONAL JOURNAL OF CANCER
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bladder cancer invasion predictability based on preoperative neutrophil–lymphocyte ratio
- (2014) Mehmet Kaynar et al. TUMOR BIOLOGY
- Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors11Grant support: The Swedish Cancer Society, the Swedish research council, the Nilsson Cancer foundation, the BioCARE Strategic Cancer Research program, the Lund Medical Faculty, and FoU Landstinget Kronoberg and Södra Regionvårdnämnden.
- (2014) Gottfrid Sjödahl et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic T Lymphocytes to Tumor Beds
- (2013) T. Lanca et al. JOURNAL OF IMMUNOLOGY
- Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance
- (2012) Xiao-wei Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Recruitment of a myeloid cell subset (CD11b/Gr1mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis*
- (2012) Lei Zhao et al. HEPATOLOGY
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- The Expression of Monocyte Chemotactic Protein-1 in Papillary Thyroid Carcinoma Is Correlated with Lymph Node Metastasis and Tumor Recurrence
- (2008) Katsuhiro Tanaka et al. THYROID
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now